Cargando…

Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2

Backgrounds: Lung adenocarcinoma is one of the most common malignant tumors, in which KEAP1-NFE2L2 pathway is altered frequently. The biological features and intrinsic heterogeneities of KEAP1/NFE2L2-mutant lung adenocarcinoma remain unclear. Methods: Multiplatform data from The Cancer Genome Atlas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiaodong, Li, Ming, Chen, Zhencong, Fan, Xiaobin, Guo, Liang, Jin, Bo, Huang, Yiwei, Wang, Qun, Wu, Liang, Zhan, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965119/ https://www.ncbi.nlm.nih.gov/pubmed/35371318 http://dx.doi.org/10.7150/jca.66241

Ejemplares similares

Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
por: Jin, Xing, et al.
Publicado: (2021)

Level and course of FEV(1 )in relation to polymorphisms in NFE2L2 and KEAP1 in the general population
por: Siedlinski, Mateusz, et al.
Publicado: (2009)

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
por: Bi, Guoshu, et al.
Publicado: (2022)

Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma
por: Sheth, Siddharth, et al.
Publicado: (2021)

Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer
por: Liu, Mengxiao, et al.
Publicado: (2022)

Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
por: Sui, Qihai, et al.
Publicado: (2022)

Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations
por: Hu, Yan, et al.
Publicado: (2020)

N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2
por: Mildenberger, Jennifer, et al.
Publicado: (2017)

Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection
por: Soto, María Elena, et al.
Publicado: (2022)

Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients
por: Sui, Qihai, et al.
Publicado: (2020)

The clinical prognostic factors of patients with stage IB lung adenocarcinoma
por: Sui, Qihai, et al.
Publicado: (2021)

Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma
por: Liang, Jiaqi, et al.
Publicado: (2022)

Systematic Identification of Multi Omics-based Biomarkers in KEAP1 Mutated TCGA Lung Adenocarcinoma
por: Namani, Akhileshwar, et al.
Publicado: (2019)

miR-23b-3p Inhibits the Oncogenicity of Colon Adenocarcinoma by Directly Targeting NFE2L3
por: Huang, Guohong, et al.
Publicado: (2021)

Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment
por: Cheng, Wanwan, et al.
Publicado: (2021)

Identification and validation of the mitochondrial function related hub genes by unsupervised machine learning and multi-omics analyses in lung adenocarcinoma
por: Jin, Xing, et al.
Publicado: (2022)

Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules
por: Lu, Tao, et al.
Publicado: (2020)

Gastrointestinal Goblet Cell Adenocarcinomas Harbor Distinctive Clinicopathological, Immune, and Genomic Landscape
por: Lin, Dong-Liang, et al.
Publicado: (2021)

NFE2L2 polymorphisms, mortality, and metabolism in the general population
por: Figarska, Sylwia M., et al.
Publicado: (2014)

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials
por: Zhu, Hongyuan, et al.
Publicado: (2021)

Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma
por: Zhao, Yue, et al.
Publicado: (2021)

Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility
por: Ji, Guiyi, et al.
Publicado: (2021)

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma
por: Hu, Zhengyang, et al.
Publicado: (2023)

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
por: von Otter, Malin, et al.
Publicado: (2010)

Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation
por: Wang, Xiaodong, et al.
Publicado: (2021)

Ferroptosis regulation by the NGLY1/NFE2L1 pathway
por: Forcina, Giovanni C., et al.
Publicado: (2022)

Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes
por: Wang, Kewei, et al.
Publicado: (2023)

LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2022)

NFE2L2 variations reduce antioxidant response in patients with Parkinson disease
por: Gui, YaXing, et al.
Publicado: (2016)

Landscape and dynamics of single tumor and immune cells in early and advanced‐stage lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2021)

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
por: Pajares, Marta, et al.
Publicado: (2016)

Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2019)

Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma
por: Lei, Jia, et al.
Publicado: (2021)

Involvement of a Transcription factor, Nfe2, in Breast Cancer Metastasis to Bone
por: Zhang, Di, et al.
Publicado: (2020)

NFE2L1-mediated proteasome function protects from ferroptosis
por: Kotschi, Stefan, et al.
Publicado: (2022)

Unravelling the role of NFE2L1 in stress responses and related diseases
por: Liu, Xingzhu, et al.
Publicado: (2023)

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported
por: Anekpuritanang, Tauangtham, et al.
Publicado: (2021)

Cardamonin Reduces Acetaminophen-Induced Acute Liver Injury in Mice via Activating Autophagy and NFE2L2 Signaling
por: Xu, Qiushi, et al.
Publicado: (2020)

CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis
por: Wang, Yanbo, et al.
Publicado: (2021)

Interaction of Genetic Variations in NFE2L2 and SELENOS Modulates the Risk of Hashimoto's Thyroiditis
por: Santos, Liliana R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lp90qasju81squ3mclae6oshg0